Sage Capital Advisors’s Amicus Therapeutics FOLD Stock Holding History
Bought
Maintained
Sold
Other funds holding FOLD
PA
ACA
PAI
Sage Capital Advisors's FOLD Position: Q4 2024 in Review
Sage Capital Advisors sold out of Amicus Therapeutics (FOLD) in Q4 2024, closing a stake of 10,400 shares — an estimated $111K sold.
Sage Capital Advisors first reported a position in FOLD in Q3 2017 and held it in 16 quarters. The position peaked at $166K in Q1 2019. 290 funds tracked by Wall St. Rank hold FOLD as of Q4 2024.
- Sage Capital Advisors reported no remaining Amicus Therapeutics position as of Q4 2024 after selling out during the quarter.
- Sage Capital Advisors sold 10,400 Amicus Therapeutics shares in Q4 2024, an estimated $111K.
- Sage Capital Advisors first reported a position in Amicus Therapeutics in Q3 2017 and held it in 16 quarters.
- Sage Capital Advisors's Amicus Therapeutics position peaked at $166K in Q1 2019.
- 290 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q4 2024.
Based on Sage Capital Advisors's 13F filing for Q4 2024, filed 10 Jan 2025.